Expert Opinion on Drug Discovery, Volume 3, Issue 1 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Discovery, Volume 3, Issue 1 (2008)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Volume 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Reviews

Article
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery
Keiran SM Smalley, Mercedes Lioni, Kazuhiro Noma, Nikolas K Haass & Meenhard Herlyn
Pages: 1-10
Published online: 19 Dec 2007
AbstractforIn vitro three-dimensional tumor microenvironment models for anticancer drug discovery | Full Text | References | PDF (1.2 MB)
  • 750 Views
  • 88 CrossRef citations
  • 0Altmetric
Article
Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone
Mark Pines PhD
Pages: 11-20
Published online: 19 Dec 2007
AbstractforTargeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone | Full Text | References | PDF (655.6 KB)
  • 195 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Development of new antituberculous agents based on new drug targets and structure–activity relationship
Haruaki Tomioka Phd, Professor
Pages: 21-49
Published online: 19 Dec 2007
AbstractforDevelopment of new antituberculous agents based on new drug targets and structure–activity relationship | Full Text | References | PDF (282.2 KB)
  • 162 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
The apelin peptides as putative targets in cardiovascular drug discovery and development
CJ Charles PhD
Pages: 51-64
Published online: 19 Dec 2007
AbstractforThe apelin peptides as putative targets in cardiovascular drug discovery and development | Full Text | References | PDF (284.8 KB)
  • 75 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Huprines for Alzheimer's disease drug development
Diego Muñoz-Torrero & Pelayo Camps
Pages: 65-81
Published online: 19 Dec 2007
AbstractforHuprines for Alzheimer's disease drug development | Full Text | References | PDF (1.4 MB)
  • 95 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Animal models for drug discovery in dystonia
HA Jinnah MD PhD, Angelika Richter, Jonathon W Mink, Guy A Caldwell, Kim A Caldwell, Pedro Gonzalez-Alegre, Mark R Cookson, Xandra O Breakefield, Mahlon R Delong & Ellen J Hess
Pages: 83-97
Published online: 19 Dec 2007
AbstractforAnimal models for drug discovery in dystonia | Full Text | References | PDF (192.4 KB)
  • 181 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Discovery and development of purine-scaffold Hsp90 inhibitors
Gabriela Chiosis, Yanlong Kang & Weilin Sun
Pages: 99-114
Published online: 19 Dec 2007
AbstractforDiscovery and development of purine-scaffold Hsp90 inhibitors | Full Text | References | PDF (620.5 KB)
  • 183 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Developing assays for kinase drug discovery – where have the advances come from?
Kurt W Vogel, Zhong Zhong, Kun Bi & Brian A Pollok
Pages: 115-129
Published online: 19 Dec 2007
AbstractforDeveloping assays for kinase drug discovery – where have the advances come from? | Full Text | References | PDF (903.6 KB)
  • 229 Views
  • 9 CrossRef citations
  • 0Altmetric

Case History

Article
Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases
Robert C Jackson PhD, Anna L Barnett PhD, Steven J McClue PhD & Simon R Green PhD
Pages: 131-143
Published online: 19 Dec 2007
AbstractforSeliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases | Full Text | References | PDF (218.8 KB)
  • 149 Views
  • 16 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery
Zhou Dongrui et al.
Review Article | Published online: 16 May 2024
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets
Guixian Zhao et al.
Review Article | Published online: 16 May 2024
Hits and misses with animal models of narcolepsy and the implications for drug discovery
Ramakrishna Nirogi et al.
Review Article | Published online: 15 May 2024
Bridging the gap between target-based and phenotypic-based drug discovery
Cecília R.C. Calado
Comment | Published online: 15 May 2024
View all latest articles